Dasatinib in Advanced Non-small Cell Lung Cancer (NSCL) With Ex Vivo and In Vivo Assessment of Tumor Target Modulation
Clinical trial NCT00858403 · TERMINATED
Trial details
- NCT number
- NCT00858403
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2010-07-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.